Chinese medical device maker Mindray Medical International Ltd. said Monday it received Food and Drug Administration approval for its portable ultrasound imaging system and a biochemistry analyzer.
Specifically, the company's M5 ultrasound system was approved along with the BS-200 automatic biochemistry analyzer.
Shares of Mindray fell 5 cents to close at $28.94.